Carregant...
Linagliptin Attenuates Diabetes-Induced Cerebral Pathological Neovascularization in a Blood Glucose-Independent Manner: Potential Role of ET-1
AIMS: We have shown that glycemic control with metformin or endothelin-1 (ET-1) inhibition with bosentan prevents and restores diabetes-mediated cerebral pathological remodeling and neovascularization. Our recent data suggest that linagliptin, a member of the dipeptidyl peptidase-4 inhibitor class o...
Guardat en:
| Publicat a: | Life Sci |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4882278/ https://ncbi.nlm.nih.gov/pubmed/26631506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2015.11.026 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|